151 related articles for article (PubMed ID: 30248050)
1. High-Density Lipoprotein Subclasses and Mild Cognitive Impairment: Study of Outcome and aPolipoproteins in Dementia (STOP-Dementia)1.
Ohtani R; Nirengi S; Nakamura M; Murase N; Sainouchi M; Kuwata Y; Takata M; Masuda Y; Kotani K; Sakane N
J Alzheimers Dis; 2018; 66(1):289-296. PubMed ID: 30248050
[TBL] [Abstract][Full Text] [Related]
2. Quantitative NMR-Based Lipoprotein Analysis Identifies Elevated HDL-4 and Triglycerides in the Serum of Alzheimer's Disease Patients.
Berezhnoy G; Laske C; Trautwein C
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293327
[TBL] [Abstract][Full Text] [Related]
3. Serum levels of vitamin E forms and risk of cognitive impairment in a Finnish cohort of older adults.
Mangialasche F; Solomon A; Kåreholt I; Hooshmand B; Cecchetti R; Fratiglioni L; Soininen H; Laatikainen T; Mecocci P; Kivipelto M
Exp Gerontol; 2013 Dec; 48(12):1428-35. PubMed ID: 24113154
[TBL] [Abstract][Full Text] [Related]
4. Association of plasma endothelial lipase levels on cognitive impairment.
Yun SM; Park JY; Seo SW; Song J
BMC Psychiatry; 2019 Jun; 19(1):187. PubMed ID: 31216999
[TBL] [Abstract][Full Text] [Related]
5. Framingham Risk Score and the Risk of Progression from Mild Cognitive Impairment to Dementia.
Viticchi G; Falsetti L; Buratti L; Sajeva G; Luzzi S; Bartolini M; Provinciali L; Silvestrini M
J Alzheimers Dis; 2017; 59(1):67-75. PubMed ID: 28582863
[TBL] [Abstract][Full Text] [Related]
6. Characterizing Aging, Mild Cognitive Impairment, and Dementia with Blood-Based Biomarkers and Neuropsychology.
Kleinschmidt M; Schoenfeld R; Göttlich C; Bittner D; Metzner JE; Leplow B; Demuth HU
J Alzheimers Dis; 2016; 50(1):111-26. PubMed ID: 26639953
[TBL] [Abstract][Full Text] [Related]
7. Biomarkers for Early Diagnostic of Mild Cognitive Impairment in Type-2 Diabetes Patients: A Multicentre, Retrospective, Nested Case-Control Study.
Xu ZP; Yang SL; Zhao S; Zheng CH; Li HH; Zhang Y; Huang RX; Li MZ; Gao Y; Zhang SJ; Zhan PY; Zhang LF; Deng L; Wei S; Liu YC; Ye JW; Ren HJ; Li N; Kong CX; Wang X; Fang L; Zhou QZ; Jiang HW; Li JR; Wang Q; Ke D; Liu GP; Wang JZ
EBioMedicine; 2016 Mar; 5():105-13. PubMed ID: 27077117
[TBL] [Abstract][Full Text] [Related]
8. Plasma High Density Lipoprotein Small Subclass is Reduced in Alzheimer's Disease Patients and Correlates with Cognitive Performance.
Pedrini S; Hone E; Gupta VB; James I; Teimouri E; Bush AI; Rowe CC; Villemagne VL; Ames D; Masters CL; Rainey-Smith S; Verdile G; Sohrabi HR; Raida MR; Wenk MR; Taddei K; Chatterjee P; Martins I; Laws SM; Martins RN;
J Alzheimers Dis; 2020; 77(2):733-744. PubMed ID: 32741823
[TBL] [Abstract][Full Text] [Related]
9. Elevated serum TC and LDL-C levels in Alzheimer's disease and mild cognitive impairment: A meta-analysis study.
Liu Y; Zhong X; Shen J; Jiao L; Tong J; Zhao W; Du K; Gong S; Liu M; Wei M
Brain Res; 2020 Jan; 1727():146554. PubMed ID: 31765631
[TBL] [Abstract][Full Text] [Related]
10. 18F-FDG PET diagnostic and prognostic patterns do not overlap in Alzheimer's disease (AD) patients at the mild cognitive impairment (MCI) stage.
Morbelli S; Bauckneht M; Arnaldi D; Picco A; Pardini M; Brugnolo A; Buschiazzo A; Pagani M; Girtler N; Nieri A; Chincarini A; De Carli F; Sambuceti G; Nobili F
Eur J Nucl Med Mol Imaging; 2017 Nov; 44(12):2073-2083. PubMed ID: 28785843
[TBL] [Abstract][Full Text] [Related]
11. The role of human kallikrein 6, clusterin and adiponectin as potential blood biomarkers of dementia.
Dukic L; Simundic AM; Martinic-Popovic I; Kackov S; Diamandis A; Begcevic I; Diamandis EP
Clin Biochem; 2016 Feb; 49(3):213-8. PubMed ID: 26515085
[TBL] [Abstract][Full Text] [Related]
12. Visual Evaluation of Medial Temporal Lobe Atrophy as a Clinical Marker of Conversion from Mild Cognitive Impairment to Dementia and for Predicting Progression in Patients with Mild Cognitive Impairment and Mild Alzheimer's Disease.
Persson K; Barca ML; Eldholm RS; Cavallin L; Šaltytė Benth J; Selbæk G; Brækhus A; Saltvedt I; Engedal K
Dement Geriatr Cogn Disord; 2017; 44(1-2):12-24. PubMed ID: 28614836
[TBL] [Abstract][Full Text] [Related]
13. Macrophage Migration Inhibitory Factor is Associated with Biomarkers of Alzheimer's Disease Pathology and Predicts Cognitive Decline in Mild Cognitive Impairment and Mild Dementia.
Oikonomidi A; Tautvydaitė D; Gholamrezaee MM; Henry H; Bacher M; Popp J
J Alzheimers Dis; 2017; 60(1):273-281. PubMed ID: 28826184
[TBL] [Abstract][Full Text] [Related]
14. Medical Journey of Patients with Mild Cognitive Impairment and Mild Alzheimer's Disease Dementia: A Cross-sectional Survey of Patients, Care Partners, and Neurologists.
Pruzin JJ; Brunton S; Alford S; Hamersky C; Sabharwal A; Gopalakrishna G
J Prev Alzheimers Dis; 2023; 10(2):162-170. PubMed ID: 36946442
[TBL] [Abstract][Full Text] [Related]
15. Interrelationship between Mini-Mental State Examination scores and biochemical parameters in patients with mild cognitive impairment and Alzheimer's disease.
Vasantharekha R; Priyanka HP; Swarnalingam T; Srinivasan AV; ThyagaRajan S
Geriatr Gerontol Int; 2017 Oct; 17(10):1737-1745. PubMed ID: 27921357
[TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein A1 in Cerebrospinal Fluid and Plasma and Progression to Alzheimer's Disease in Non-Demented Elderly.
Slot RE; Van Harten AC; Kester MI; Jongbloed W; Bouwman FH; Teunissen CE; Scheltens P; Veerhuis R; van der Flier WM
J Alzheimers Dis; 2017; 56(2):687-697. PubMed ID: 28035918
[TBL] [Abstract][Full Text] [Related]
17. Cerebrospinal fluid cortisol and clinical disease progression in MCI and dementia of Alzheimer's type.
Popp J; Wolfsgruber S; Heuser I; Peters O; Hüll M; Schröder J; Möller HJ; Lewczuk P; Schneider A; Jahn H; Luckhaus C; Perneczky R; Frölich L; Wagner M; Maier W; Wiltfang J; Kornhuber J; Jessen F
Neurobiol Aging; 2015 Feb; 36(2):601-7. PubMed ID: 25435336
[TBL] [Abstract][Full Text] [Related]
18. High density lipoprotein and its apolipoprotein-defined subspecies and risk of dementia.
Koch M; DeKosky ST; Goodman M; Sun J; Furtado JD; Fitzpatrick AL; Mackey RH; Cai T; Lopez OL; Kuller LH; Mukamal KJ; Jensen MK
J Lipid Res; 2020 Mar; 61(3):445-454. PubMed ID: 31892526
[TBL] [Abstract][Full Text] [Related]
19. Frequency and subgroups of neuropsychiatric symptoms in mild cognitive impairment and different stages of dementia in Alzheimer's disease.
Siafarikas N; Selbaek G; Fladby T; Šaltytė Benth J; Auning E; Aarsland D
Int Psychogeriatr; 2018 Jan; 30(1):103-113. PubMed ID: 28927477
[TBL] [Abstract][Full Text] [Related]
20. Design and first baseline data of the DZNE multicenter observational study on predementia Alzheimer's disease (DELCODE).
Jessen F; Spottke A; Boecker H; Brosseron F; Buerger K; Catak C; Fliessbach K; Franke C; Fuentes M; Heneka MT; Janowitz D; Kilimann I; Laske C; Menne F; Nestor P; Peters O; Priller J; Pross V; Ramirez A; Schneider A; Speck O; Spruth EJ; Teipel S; Vukovich R; Westerteicher C; Wiltfang J; Wolfsgruber S; Wagner M; Düzel E
Alzheimers Res Ther; 2018 Feb; 10(1):15. PubMed ID: 29415768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]